Interventional Cardiology: Peripheral Vascular Disease Therapeutic Devices
In 2019, Meddevicetracker estimates that the global market for peripheral vascular disease (PVD) therapy devices totaled nearly $5.2bn; the market is anticipated to increase at a CAGR of 5.4% over the next five years. Endovascular stent sales (including bare-metal stents and drug-eluting stents) accounted for the largest share of total product sales in 2019, with nearly half. The largest driver of market growth is the increasing prevalence of cardiovascular disease (CVD) as a result of the aging of the population as well as an increasing prevalence of CVD risk factors such as diabetes, high cholesterol, and obesity. Other drivers include advances in diagnostics, technological advances, growing preference for minimally invasive therapies, and increasing demand for improved healthcare in emerging markets. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global markets for angioplasty catheters, vascular stents, atherectomy catheters, thrombectomy catheters, and chronic total occlusion crossing devices for PVD applications. The report provides forecasts for the 2019-24 time period, for the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the rest-of-world markets.